• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非重度血友病诊断与管理中的挑战

Challenges in the Diagnosis and Management of Non-Severe Hemophilia.

作者信息

Boeriu Estera, Arghirescu Teodora Smaranda, Serban Margit, Patrascu Jenel Marian, Boia Eugen, Jinca Cristian, Schramm Wolfgang, Traila Adina, Ursu Cristina Emilia

机构信息

Department of Pediatrics, Division of Onco-Hematology, Victor Babes University of Medicine and Pharmacy Timisoara, 300041 Timisoara, Romania.

Onco-Hematology Research Unit, Romanian Academy of Medical Sciences, Children Emergency Hospital "Louis Turcanu" Timisoara, European Hemophilia Treatment Centre, 300011 Timisoara, Romania.

出版信息

J Clin Med. 2022 Jun 9;11(12):3322. doi: 10.3390/jcm11123322.

DOI:10.3390/jcm11123322
PMID:35743393
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9225229/
Abstract

(1) Background: Mild and moderate hemophilia, synonymous with non-severe hemophilia (NSH), are of constant interest for the clinicians. Bleeding occurs usually after trauma, injury, surgery, or inhibitor development, sometimes leading to a shift of the clinical phenotype from mild to severe, even with life-threatening and unexpected outcomes. (2) Methods: We performed a retrospective observational study conducted on 112 persons with congenital coagulopathies, 26 of them with NSH, admitted to our clinic in the period 2000 to 2022. For the diagnosis, we used laboratory studies (complete blood cell count, coagulation assays, biochemistry, thromboelastography, genetic tests) and imaging investigations (X-ray, ultrasound, CT, MRI). We selected four cases confronted with pitfalls of diagnosis and evolution in order to illustrate the sometimes provocative field of NSH. (3) Results: Confronted with challenging cases with under-, missed or delayed diagnosis and severe consequences, we aimed at presenting four such selected cases with mild or moderate hemophilia, real pitfalls in our clinical activity. (4) Conclusions: In the field of NSH, if not timely recognized, tending sometimes to remain ignored by caregivers and patients themselves, we can be confronted with challenging diagnostic situations and life-threatening bleeds.

摘要

(1)背景:轻度和中度血友病,即非重度血友病(NSH),一直是临床医生关注的焦点。出血通常发生在创伤、损伤、手术或抑制剂形成之后,有时会导致临床表型从轻度转变为重度,甚至出现危及生命和意想不到的后果。(2)方法:我们对2000年至2022年期间收治到我们诊所的112例先天性凝血病患者进行了一项回顾性观察研究,其中26例为非重度血友病患者。诊断时,我们采用了实验室检查(全血细胞计数、凝血试验、生化检查、血栓弹力图、基因检测)和影像学检查(X线、超声、CT、MRI)。我们挑选了4例在诊断和病情发展过程中遇到陷阱的病例,以说明非重度血友病这一有时颇具挑战性的领域。(3)结果:面对诊断不足、漏诊或延误诊断且后果严重的具有挑战性的病例,我们旨在呈现4例这样的轻度或中度血友病精选病例,它们是我们临床工作中实实在在的陷阱。(4)结论:在非重度血友病领域,如果未能及时识别,有时会倾向于被护理人员和患者自身忽视,我们可能会面临具有挑战性的诊断情况和危及生命的出血。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dbbe/9225229/7bca5a061fda/jcm-11-03322-g0A2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dbbe/9225229/7503273b5486/jcm-11-03322-g0A1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dbbe/9225229/7bca5a061fda/jcm-11-03322-g0A2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dbbe/9225229/7503273b5486/jcm-11-03322-g0A1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dbbe/9225229/7bca5a061fda/jcm-11-03322-g0A2.jpg

相似文献

1
Challenges in the Diagnosis and Management of Non-Severe Hemophilia.非重度血友病诊断与管理中的挑战
J Clin Med. 2022 Jun 9;11(12):3322. doi: 10.3390/jcm11123322.
2
Discovery of Type 3 von Willebrand Disease in a Cohort of Patients with Suspected Hemophilia A in Côte d'Ivoire.在科特迪瓦疑似甲型血友病患者队列中发现3型血管性血友病。
Mediterr J Hematol Infect Dis. 2020 Mar 1;12(1):e2020019. doi: 10.4084/MJHID.2020.019. eCollection 2020.
3
Hemophilia and von Willebrand's disease: 2. Management. Association of Hemophilia Clinic Directors of Canada.血友病和血管性血友病:2. 管理。加拿大血友病诊所主任协会
CMAJ. 1995 Jul 15;153(2):147-57.
4
Emerging Issues in Diagnosis, Biology, and Inhibitor Risk in Mild Hemophilia A.轻度甲型血友病诊断、生物学及抑制剂风险方面的新问题
Semin Thromb Hemost. 2016 Jul;42(5):507-12. doi: 10.1055/s-0036-1571309. Epub 2016 May 5.
5
The diagnosis and management of congenital hemophilia.先天性血友病的诊断和治疗。
Semin Thromb Hemost. 2012 Oct;38(7):727-34. doi: 10.1055/s-0032-1326786. Epub 2012 Sep 25.
6
Overall hemostasis potential and aPTT-clot waveform analysis as powerful laboratory diagnostic tools for identification of hemophilia A patients with unexpected bleeding phenotype.总体止血潜能和 aPTT-凝块波形分析是血友病 A 患者伴意外出血表型鉴定的强有力实验室诊断工具。
Int J Lab Hematol. 2021 Apr;43(2):273-280. doi: 10.1111/ijlh.13347. Epub 2020 Sep 23.
7
Congenital hemophilia A with low activity of factor XII: a case report and literature review.先天性因子 XII 活性低下型血友病 A: 1 例报告并文献复习。
Ital J Pediatr. 2021 Oct 11;47(1):204. doi: 10.1186/s13052-021-01137-x.
8
Uncontrollable bleeding after tooth extraction from asymptomatic mild hemophilia patients: two case reports.拔牙后无症状轻度血友病患者出现无法控制的出血:两例报告。
BMC Oral Health. 2022 Mar 13;22(1):69. doi: 10.1186/s12903-022-02074-9.
9
Hemophilia A in the third millennium.血友病 A 在第三个千年。
Blood Rev. 2013 Jul;27(4):179-84. doi: 10.1016/j.blre.2013.06.002. Epub 2013 Jun 28.
10
Discrepancy between the results of one-stage and chromogenic factor VIII: C assays in patients with mild/moderate hemophilia A.一期法和显色因子 VIII:C 检测在轻/中度血友病 A 患者中的结果差异。
Blood Coagul Fibrinolysis. 2020 Dec;31(8):530-535. doi: 10.1097/MBC.0000000000000959.

引用本文的文献

1
Nonsevere Hemophilia: The Need for a Renewed Focus and Improved Outcomes.非重度血友病:需要重新聚焦并改善治疗结果。
Semin Thromb Hemost. 2025 Feb;51(1):58-67. doi: 10.1055/s-0044-1786358. Epub 2024 May 11.
2
Patient perspective on living with mild hemophilia in Germany: results from a nationwide survey.德国血友病患者对轻度血友病生活的看法:一项全国性调查结果
Front Med (Lausanne). 2024 Feb 5;11:1347024. doi: 10.3389/fmed.2024.1347024. eCollection 2024.

本文引用的文献

1
The bleeding phenotype in people with nonsevere hemophilia.非重型血友病患者的出血表型。
Blood Adv. 2022 Jul 26;6(14):4256-4265. doi: 10.1182/bloodadvances.2022007620.
2
Multimer Analysis of Von Willebrand Factor in Von Willebrand Disease with a Hydrasys Semi-Automatic Analyzer-Single-Center Experience.使用Hydrasys半自动分析仪对血管性血友病因子进行多聚体分析——单中心经验
Diagnostics (Basel). 2021 Nov 20;11(11):2153. doi: 10.3390/diagnostics11112153.
3
Clinical phenotype of severe and moderate haemophilia: Who should receive prophylaxis and what is the target trough level?
重度和中度血友病的临床表型:谁应该接受预防治疗,目标低谷水平是多少?
Haemophilia. 2021 Mar;27(2):192-198. doi: 10.1111/hae.14201. Epub 2021 Feb 27.
4
Translating the success of prophylaxis in haemophilia to von Willebrand disease.将预防治疗在血友病中的成功转化到血管性血友病中。
Thromb Res. 2021 Mar;199:67-74. doi: 10.1016/j.thromres.2020.12.030. Epub 2021 Jan 6.
5
Joint health and treatment modalities in Nordic patients with moderate haemophilia A and B - The MoHem study.北欧中重度 A 型和 B 型血友病患者的关节健康和治疗方式 - MoHem 研究。
Haemophilia. 2020 Sep;26(5):891-897. doi: 10.1111/hae.14114. Epub 2020 Jul 27.
6
Burden of mild haemophilia A: Systematic literature review.轻度血友病 A 的负担:系统文献回顾。
Haemophilia. 2019 Sep;25(5):755-763. doi: 10.1111/hae.13777. Epub 2019 Jul 11.
7
Current Trend of Invasive Orthopaedic Interventions for People with Haemophilia in Romania: Single Centre Experience.罗马尼亚血友病患者接受侵入性骨科干预的现状:单中心经验。
Hamostaseologie. 2019 Nov;39(4):377-382. doi: 10.1055/s-0039-1677884. Epub 2019 Feb 13.
8
Moderate haemophilia in focus.聚焦中度血友病。
Haemophilia. 2019 Mar;25(2):187-188. doi: 10.1111/hae.13677. Epub 2019 Jan 16.
9
Treatment regimens and outcomes in severe and moderate haemophilia A in the UK: The THUNDER study.英国重度和中度甲型血友病的治疗方案和结果:THUNDER 研究。
Haemophilia. 2019 Mar;25(2):205-212. doi: 10.1111/hae.13616. Epub 2018 Nov 8.
10
Diagnosis and care of patients with mild haemophilia: practical recommendations for clinical management.轻度血友病患者的诊断和护理:临床管理的实用建议。
Blood Transfus. 2018 Nov;16(6):535-544. doi: 10.2450/2017.0150-17. Epub 2017 Nov 14.